Company Filing History:
1 out of 10 
2 out of 832,843 Years Active: 2002-2004
Title: David Griffen: Innovator in Therapeutic Peptides
Introduction
David Griffen is a notable inventor based in Greenville, NC (US). He has made significant contributions to the field of therapeutic peptides, holding a total of three patents. His work focuses on innovative solutions for various medical conditions, showcasing his dedication to advancing healthcare.
Latest Patents
Griffen's latest patents include "Contulakin-G, analogs thereof and uses therefor." This invention is centered around contulakin-G, a native glycosylated peptide, and its derivatives. The patent outlines the use of this peptide as a therapeutic agent for a wide range of conditions, including anti-seizure, anti-inflammatory, and anti-psychotic applications. It also addresses various neurological and gastrointestinal disorders, highlighting the peptide's potential in treating complex health issues.
Career Highlights
Throughout his career, David Griffen has worked with several companies, including Cognetix, Inc. His experience in the industry has allowed him to develop and refine his innovative ideas, contributing to the advancement of therapeutic peptides. His work has garnered attention for its potential impact on patient care and treatment options.
Collaborations
Griffen has collaborated with notable individuals in his field, including A Grey Craig and Baldomero M Olivera. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.
Conclusion
David Griffen's contributions to the field of therapeutic peptides demonstrate his commitment to improving healthcare through innovation. His patents reflect a deep understanding of complex medical challenges and a drive to create effective solutions.